Portal aids CMO/client communication; Ion technology from Russia;

> An Internet portal from software maker SourceSolution allows CMOs and CROs to securely exchange data, documents and project information with their clients. Release

> A project in Russia aims to develop ophthalmic treatments to be manufactured using Skulachev ion targeted-antioxidant technology. Article

> QRxPharma and China Aoxing are co-developing MoxDuo IV, an intravenous formulation of the former's morphine and oxycodone Dual-Opioid treatment of moderate to severe pain. Release 

> A multi-million dollar federal grant has paved the way for G-Con to start work on a vaccine production plant in Bryan, TX. Item

> California-based generics maker SOHM has allied itself with an injectable manufacturing unit in India, gaining additional capacity for injectable and drops-based products. Announcement

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.